Author

L. Puentes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

E. Arai· 1 shared J. Shi· 1 shared M. Deb· 1 shared P. Deraska· 1 shared P. Verma· 1 shared R. A. Greenberg· 1 shared R. B. Faryabi· 1 shared R. H. Mach· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

E. Arai

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination deficient cells

P. Verma, Y. Zhou, Z. Cao, P. Deraska, M. Deb, E. Arai, W. Li, Y. Shao, Y. Li, L. Puentes, s. patankar, R. H. Mach, R. B. Faryabi, J. Shi, R. A. Greenberg

This study identifies ALC1 as a key determinant of PARPi toxicity in HR-deficient cells by linking PARP-dependent chromatin remodeling to PARPi response.

bioRxiv · Dec 16, 2020Cancer Biology